| |
| |
|
| Insider
Information: |
Legault Pierre |
| Relationship: |
Director |
| City: |
Berkeley Heights |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
964,435 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,400,296 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
964,435 |
|
|
| Total
Value |
$1,400,296 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rite Aid Corp |
RAD |
Senior Executive VP |
2008-06-26 |
206,505 |
2007-06-07 |
0 |
Premium* |
|
|
Nephrogenex, Inc. |
NRX |
Chief Executive Office... |
2015-11-10 |
659,430 |
|
0 |
Premium* |
|
|
Urovant Sciences Ltd. |
UROV |
Director |
2021-03-29 |
0 |
2020-01-10 |
0 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
|
2024-02-07 |
65,000 |
2021-02-03 |
0 |
Premium* |
|
|
Bicycle Therapeutics Ltd |
BCYC |
Director |
2024-01-02 |
33,500 |
2021-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
65,000 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
33,500 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
48,000 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2023-01-13 |
4 |
AS |
$27.00 |
$405,000 |
D/D |
(15,000) |
32,000 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2023-01-13 |
4 |
OE |
$13.58 |
$203,700 |
D/D |
15,000 |
37,000 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2023-01-12 |
4 |
AS |
$26.74 |
$641,782 |
D/D |
(24,000) |
32,000 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2023-01-12 |
4 |
OE |
$9.47 |
$227,280 |
D/D |
24,000 |
56,000 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,500 |
21,500 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2022-08-05 |
4 |
AS |
$23.02 |
$552,382 |
D/D |
(24,000) |
32,000 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2022-08-05 |
4 |
OE |
$8.93 |
$221,320 |
D/D |
24,000 |
46,000 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
32,000 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2021-12-22 |
4 |
OE |
$8.48 |
$829,853 |
D/D |
97,860 |
97,860 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2021-12-22 |
4 |
AS |
$58.01 |
$5,676,859 |
D/D |
(97,860) |
0 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2021-12-22 |
4 |
OE |
$7.88 |
$189,120 |
D/D |
24,000 |
40,000 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2021-12-22 |
4 |
AS |
$22.01 |
$528,206 |
D/D |
(24,000) |
16,000 |
0 |
% |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2021-12-21 |
4 |
OE |
$8.44 |
$375,892 |
D/D |
44,537 |
44,537 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2021-12-21 |
4 |
AS |
$57.11 |
$2,543,508 |
D/D |
(44,537) |
0 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2021-12-20 |
4 |
OE |
$8.41 |
$63,941 |
D/D |
7,603 |
7,603 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2021-12-20 |
4 |
AS |
$57.02 |
$433,523 |
D/D |
(7,603) |
0 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2021-12-20 |
4 |
AS |
$21.01 |
$420,250 |
D/D |
(20,000) |
16,000 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
|
– • – |
2021-12-20 |
4 |
OE |
$7.08 |
$141,600 |
D/D |
20,000 |
36,000 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2021-04-08 |
4 |
AS |
$31.40 |
$787,588 |
D/D |
(24,838) |
0 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2021-04-08 |
4 |
OE |
$8.74 |
$217,084 |
D/D |
24,838 |
24,838 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Director |
– • – |
2021-04-05 |
4 |
AS |
$31.07 |
$5,033 |
D/D |
(162) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
